REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSISPRNewsWire • 03/28/26
Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 03/17/26
Amgen Inc. (AMGN) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha • 03/11/26
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained24/7 Wall Street • 03/10/26
Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in FocusZacks Investment Research • 03/09/26
Amgen Inc. (AMGN) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha • 03/02/26